Systemic Inflammation Precedes Microalbuminuria in Diabetes
نویسندگان
چکیده
منابع مشابه
Microalbuminuria in diabetes mellitus.
ica is reaching epidemic proportions and is expected to double by 2025. Over 5% of the population is known to have diabetes, and as many as another 2.5% are estimated to have the disease without knowing it. The prevalence of diabetes is increasing faster in the First Nations population than in the general population, and the onset is occurring at ever earlier ages. Diabetes is the most common c...
متن کاملEndothelial dysfunction precedes development of microalbuminuria in IDDM.
In patients with insulin-dependent diabetes mellitus (IDDM), microalbuminuria is a predictor of widespread severe microangiopathy and macroangiopathy. Patients with microalbuminuria show generalized dysfunction of the vascular endothelium, but it is unknown whether endothelial dysfunction precedes the development of microalbuminuria. We examined a cohort of 17 IDDM patients at baseline and on t...
متن کاملLow-grade inflammation and microalbuminuria in hypertension.
UNLABELLED Background- Albuminuria and C-reactive protein (CRP), a marker of systemic low-grade inflammation, are frequently elevated in essential hypertension and predict cardiovascular prognosis independent of conventional risk factors. However, in spite of their potentially important links, the interrelationships between the 2 parameters have not been explored in depth in hypertensive patien...
متن کاملMicroalbuminuria and macroalbuminuria in type 2 diabetes.
BACKGROUND Type 2 diabetes is the leading cause of end stage renal disease worldwide. Prevalence of diabetic nephropathy (DN) varies in the different ethnic groups. Nepal is country with great ethnic diversity. This study has been done to find the prevalence of microalbuminuria and macroalbuminuria in the two ethnic groups Jyapu and Brahmin. METHODS In our study we have included two ethnic gr...
متن کاملPreventing microalbuminuria in type 2 diabetes.
BACKGROUND The multicenter double-blind, randomized Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) was designed to assess whether angiotensin-converting-enzyme inhibitors and non-dihydropyridine calcium-channel blockers, alone or in combination, prevent microalbuminuria in subjects with hypertension, type 2 diabetes mellitus, and normal urinary albumin excretion. METHODS We studi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kidney International Reports
سال: 2019
ISSN: 2468-0249
DOI: 10.1016/j.ekir.2019.06.005